awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34041573-5DF986CB-325D-4AEA-948D-E3C419CAE8B9
Q34041573-5DF986CB-325D-4AEA-948D-E3C419CAE8B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34041573-5DF986CB-325D-4AEA-948D-E3C419CAE8B9
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
P2860
Q34041573-5DF986CB-325D-4AEA-948D-E3C419CAE8B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34041573-5DF986CB-325D-4AEA-948D-E3C419CAE8B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a8ec4593e6d5af2176a6110cc2528cd36794cb94
P2860
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.